| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.08. | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT UPDATE REGARDING CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE ... | 2 | HKEx | ||
| YICHANG HEC CHANGJIANG PHARMACEUTICAL Aktie jetzt für 0€ handeln | |||||
| 05.08. | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT WITHDRAWAL OF LISTING OF H SHARES AND EXPECTED TIMELINE FOR THE WITHDRAWAL OF LISTING AND THE IMPLEMENTATION ... | 1 | HKEx | ||
| 31.07. | HEC CJ PHARM (01558): SPECIAL DIVIDEND (UPDATED) | - | HKEx | ||
| 31.07. | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT IN RESPECT OF THE SPECIAL DIVIDEND | - | HKEx | ||
| 23.07. | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT RESULTS OF EXERCISE OF RIGHT OF DISSENTING SHAREHOLDERS | - | HKEx | ||
| 22.07. | HEC CJ PHARM (01558): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE | 3 | HKEx | ||
| 21.07. | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT (1) POLL RESULTS OF THE EGM AND THE H SHAREHOLDERS' CLASS MEETING HELD ON MONDAY, 21 JULY 2025 RELATING TO THE ... | 1 | HKEx | ||
| 07.07. | HEC CJ PHARM (01558): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE | 1 | HKEx | ||
| 30.06. | HEC CJ PHARM (01558): SPECIAL DIVIDEND (UPDATED) | - | HKEx | ||
| 27.06. | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT PROPOSED CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE PHARMA ... | - | HKEx | ||
| 26.06. | HEC CJ PHARM (01558): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE | - | HKEx | ||
| 18.06. | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT PROPOSED PRE-CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE PHARMA ... | - | HKEx | ||
| 18.06. | HEC CJ PHARM (01558): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE | - | HKEx | ||
| 10.06. | HEC CJ PHARM (01558): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE | 3 | HKEx | ||
| 09.06. | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT MONTHLY UPDATE IN RELATION TO THE PROPOSED PRE-CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL ... | 1 | HKEx | ||
| 29.05. | HEC CJ PHARM (01558): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 29 MAY 2025 | - | HKEx | ||
| 28.05. | HEC CJ PHARM (01558): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE | 1 | HKEx | ||
| 09.05. | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT MONTHLY UPDATE IN RELATION TO THE PROPOSED PRE-CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL ... | - | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SANOFI | 87,50 | -0,14 % | Dividenden-Garant Sanofi: Starke Zahlen - das treibt an | Mit einem Plus von zeitweise gut zwei Prozent zählt die Aktie von Sanofi am Freitag zu den größten Gewinnern im EuroStoxx 50. Starke Zahlen zum dritten Quartal schieben den französischen Pharma-Wert... ► Artikel lesen | |
| GSK | 19,920 | +6,10 % | GSK und US-Partner Alector stellen Tests an Demenzmittel nach Studienflop ein | LONDON (dpa-AFX) - Der Pharmakonzern GSK hat einen Flop bei seinen Forschungsarbeiten an einem Demenzmittel erlitten. Wie das Unternehmen am Mittwoch zusammen mit seinem Partner Alector verkündete... ► Artikel lesen | |
| ABBVIE | 194,00 | -0,51 % | AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib (RINVOQ) in Adults and Adolescents with Vitiligo | In two replicate Phase 3 studies, upadacitinib (RINVOQ ® ) achieved the co-primary endpoints of 50% reduction in Total Vitiligo Area Scoring Index (T-VASI... ► Artikel lesen | |
| ELI LILLY | 706,30 | +0,50 % | Eli Lilly - LLY: Die Pharma-Aktie sendet starke bullische Signale, aber …! | Q3-Zahlen in Kürze! Neue Kursrallye bei der Eli-Lilly-Aktie (LLY)? Orforglipron in Phase 3 - besser als Diabetes-Medikament Farxiga von AstraZeneca? GLP-1-Medikament als Tablette statt Spritze könnte... ► Artikel lesen | |
| TEVA | 17,300 | -0,57 % | »Wirtschaftlich nicht tragfähig«: Ratiopharm prüft Marktrückzug von Tamoxifen | ||
| BIOTEST | 29,200 | -2,67 % | EQS-News: Biotest AG: Absage der außerordentlichen Hauptversammlung am 28. Oktober 2025 | EQS-News: Biotest AG
/ Schlagwort(e): Hauptversammlung
Biotest AG: Absage der außerordentlichen Hauptversammlung am 28. Oktober 2025
23.10.2025 / 13:16 CET/CEST
Für... ► Artikel lesen | |
| SINOPHARM | 2,140 | +0,56 % | Sinopharm Group Co. Ltd. Nine Months Sales Decline | ||
| CSPC PHARMA | 0,862 | +1,56 % | CSPC PHARMA (01093): UNAUDITED FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2025 | ||
| SANTHERA PHARMACEUTICALS | 10,960 | +0,37 % | Santhera Pharmaceuticals Holding AG: Santhera Secures Agreement with Biomedica for the Distribution of AGAMREE (Vamorolone) in Russia | Pratteln, Switzerland, October 9, 2025 - Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Biomedica for the distribution of AGAMREE® (vamorolone) in Russia,... ► Artikel lesen | |
| WUXI BIOLOGICS | 4,100 | +1,07 % | WuXi Biologics-Aktie leicht im Plus (4,441 €) | Das Wertpapier von WuXi Biologics notiert heute fester. Das Papier kostete zuletzt 4,44 Euro. Ein Preisanstieg in Höhe von 17 Cent erfreut derzeit die Aktionäre von WuXi Biologics. Zur Stunde kostet... ► Artikel lesen | |
| OPKO HEALTH | 1,268 | +1,75 % | OPKO Health Q3 Earnings Preview | ||
| UNITED THERAPEUTICS | 388,60 | -1,12 % | United Therapeutics Q3 Earnings Beat Estimates, Revenues Miss Mark | ||
| SHANGHAI FOSUN PHARMACEUTICAL | 2,502 | -1,42 % | Fangzhou Inc.: Fangzhou and Fosun Pharma Forge Strategic Alliance to Deliver AI-Powered Psoriasis Management | SHANGHAI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leader in AI-driven Internet healthcare solutions, and Shanghai Fosun Pharmaceutical (Group)... ► Artikel lesen | |
| GEDEON RICHTER | 27,000 | +1,35 % | Gedeon Richter Plc.: Long-term Commitment to Treating Endometriosis and Improving Women's Quality of Life - Gedeon Richter at the World Congress on Endometriosis | SYDNEY, May 28, 2025 /PRNewswire/ --
Gedeon Richter had a strong presence at the World Congress of Endometriosis held this year in Sydney, Australia between 21-24 May 2025. As a Platinum... ► Artikel lesen | |
| DR REDDYS | 11,800 | -3,28 % | Dr. Reddy's Laboratories Q2 Profit Rises | NEW DELHI (dpa-AFX) - Dr. Reddy's Laboratories Ltd. (ROY) reported, under IFRS standards, that its second quarter profit attributable to equity holders of the parent company increased to INR... ► Artikel lesen |